MIDI is a strategic FDA QMSR & ISO-13485 compliant biopharmaceutical instrumentation (and disposable) development consulting firm with over 50+ years’ experience servicing clientele utilizing our Deve
...
Taiho Ventures, LLC is the corporate venture capital arm of Taiho Pharmaceutical Co., Ltd., a Japanese specialty pharmaceutical company focusing on oncology, allergy and immunology, and urology.
Trinity Capital Inc. (NASDAQ: TRIN) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sourc
...
WBB Asset Management* leverages the proprietary research and analytics developed at the firm to identify and invest in emerging life science companies with potentially disruptive technologies.
Fortress’ intellectual property strategy manages approximately $3.0 billion and invests in patent-rich assets. The firm’s investments fall into two categories; growth capital to patent-rich companies,
...
Global Emerging Markets (“GEM”) is a $3.4 billion alternative investment group that manages a diverse set of investment vehicles focused on emerging markets across the world.